Elkfork Partners’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$127K Buy
9,548
+448
+5% +$5.96K ﹤0.01% 914
2019
Q2
$128K Buy
9,100
+252
+3% +$3.55K ﹤0.01% 901
2019
Q1
$163K Hold
8,848
﹤0.01% 839
2018
Q4
$231K Buy
+8,848
New +$231K 0.01% 727